Tdspharm Co., Ltd. (KOSDAQ:464280)
South Korea · Delayed Price · Currency is KRW 10,210
+50 (0.49%)
Sep 19, 2025, 3:30 PM KST
Tdspharm Market Cap
Tdspharm has a market cap or net worth of 56.46 billion as of September 19, 2025. Its market cap has decreased by -75.89% in one year.
Market Cap
56.46B
Enterprise Value
34.41B
Revenue
22.94B
Ranking
n/a
PE Ratio
19.69
Stock Price
10,210.00
Market Cap Chart
Since August 21, 2024, Tdspharm's market cap has decreased from 287.56B to 56.46B, a decrease of -80.37%. That is a compound annual growth rate of -77.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 19, 2025 | 56.46B | -22.89% |
| Dec 30, 2024 | 73.22B | -74.54% |
| Aug 21, 2024 | 287.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 72.88T |
| Celltrion | 37.63T |
| ALTEOGEN | 25.25T |
| SK Biopharmaceuticals | 8,888.55B |
| Yuhan | 8,872.07B |
| Peptron | 6,750.37B |
| PharmaResearch | 6,202.62B |
| ABL Bio | 5,910.48B |